Tailoring the field and indication of adjuvant pelvic radiation for patients with FIGO stage Ib lymph nodes-negative cervical carcinoma following radical surgery based on the GOG score - A pilot study

Annals of the Academy of Medicine Singapore

Volumn 33, Issue 4, 2004, Pages 467-472

  Rushdan, M N ^a,b   Tay, E H ^b   Khoo Tan, H S ^c   Lee, K M ^c   Low, J H ^b   Ho, T H ^b   Yam, K L ^b  

^a Alor Setar Hospital Malaysia   (Malaysia)

^b KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Cervix; Modified field; Radiotherapy; Small field; Wertheim's hysterectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GYNECOLOGIC ONCOLOGY GROUP SCORING SYSTEM; HUMAN; HYSTERECTOMY; INTERNATIONAL FEDERATION OF OBSTETRICS AND GYNECOLOGY STAGING; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MODIFIED FIELD RADIOTHERAPY; PELVIS; PELVIS RADIOTHERAPY; PILOT STUDY; RADIATION FIELD; RECURRENCE RISK; RECURRENT CANCER; RISK ASSESSMENT; SCORING SYSTEM; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA; WERTHEIM OPERATION;

EID: 4644229609     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-40.
2. Newton M. Radical hysterectomy or radiotherapy for stage 1 cervical cancer. A prospective comparison with 5 and 10 years follow-up. Am J Obstet Gynecol 1975;123:535-42.
3. Curtin JP, Hoskins WJ, Venkatraman ES, Almadrones L, Podratz KC, Long H, et al. Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy: a randomized phase III trial. Gynecol Oncol 1996;61:3-10.
4. Sevin BU, Lu Y, Bloch DA, Nadji M, Koechli OR, Averette HE. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. Cancer 1996;78: 1438-46.
5. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage Ib squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990:38:352-7.
6. Lai CH, Chang HC, Chang TC, Hsueh S, Tang SG. Prognostic factors and impacts of adjuvant therapy in early-stage cervical carcinoma with pelvic node metastases. Gynecol Oncol 1993;51:390-6.
7. Atkovar G, Uzel O, Ozsahin M, Koca S, Sahinler I, Okkan S, et al. Postoperative radiotherapy in carcinoma of the cervix: treatment results and prognostic factors. Radiother Oncol 1995;35:198-205.
8. Lin HH, Cheng WF, Chan KW, Chang DY, Chen CK, Huang SC. Risk factors for recurrence in patients with stage Ib, IIa and IIb cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Obstet Gynecol 1996;88:274-9.
9. Schorge JO, Molpus KL, Koelliker D, Nikrui N, Goodman A, Fuller AF Jr. Stage Ib and IIa cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy. Gynecol Oncol 1997;66:31-5.
10. Hart K, Han I, Deppe G, Malviya V, Malone J Jr, Christensen C, et al. Postoperative radiation for cervical cancer with pathologic risk factors. Int J Radiat Oncol Biol Phys 1997;37:833-8.
11. Tsai CS, Lai CH, Wang CC, Chang JT, Chang TC, Tseng CJ, et al. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol Oncol 1999;75:328-33.
12. Kim SM, Choi HS, Byun JS. Overall 5-year survival rate and prognostic factors in patients with stage Ib and IIa cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. Int J Gynecol Cancer 2000;10:305-12.
13. Okada M, Kigawa J, Minagawa Y, Kanamori Y, Shimada M, Takahashi M, et al. Indication and efficacy of radiation therapy following radical surgery in patients with stage Ib to IIb cervical cancer. Gynecol Oncol 1998;70:61-4.
14. Sedlis A, Bundy BN, Rotman M, Lentz SS, Muderspach LI. Treatment of selected patients with stage lb carcinoma of the cervix treated with radical hysterectomy and pelvic lymphadenectomy: pelvic radiation therapy versus no further therapy (a GOG study). Gynecol Oncol 1999;54:571-3
15. Kridelka FJ, Berg DO, Neuman M, Edwards LS, Robertson G, Grant PT, et al. Adjuvant small field pelvic radiation for patients with high risk, stage Ib lymph node-negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study. Cancer 1999;86: 2059-65.
16. Fiorica JV, Roberts WS, Greenberg H, Hoffman MS, LaPolla JP, Cavanagh D. Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy. Gynecol Oncol 1990;36:343-7.
17. Barter JF, Soong SJ, Shingleton HM, Hatch KD, Orr JW Jr. Complications of combined radical hysterectomy - postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol 1989;32:292-6.
18. Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44:265-72.
19. Chassagne D, Sismondi P, Horiot JC, Sinistrero G, Bey P, Zola P, et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 1993;26:195-202.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
21. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema, Consensus document of the International Society of Lymphology Executive Committee. Lymphology 1995;28:113-7.
22. Averette HE, Method MV, Sevin BU, Penalver MA. Radical abdominal hysterectomy in the primary management of invasive cervical cancer. In: Rubin SC, Hoskins WJ, editors. Cervical Cancer and Preinvasive Neoplasia. Philadelphia: Lippincott-Raven Publishers, 1996:189-206.
23. Samlal RAK, van der Velden J, Ketting BW, Gonzales D, Kate FJW, Harts AAM, et al. Disease free interval and recurrence pattern after the Okabayashi variant of Wertheim's radical hysterectomy for stage Ib and IIa cervical carcinoma. Int J Gynecol Cancer 1996;6:120.
24. Burke TW, Hoskins WJ, Heller PB, Bibro MC, Weiser EB, Park RC. Prognostic factors associated with radical hysterectomy failure. Gynecol Oncol 1987;26:153-9.
25. Soisson AP, Soper JT, Clarke-Pearson DL, Berchuck A, Montana G, Creasman WT. Adjuvant radiotherapy following radical hysterectomy for patients with stage Ib and IIa cervical cancer. Gynecol Oncol 1990;37:390-5.
26. Larson DM, Stringer CA, Copeland LJ, Gershenson DM, Malone JM Jr, Rutledge FN. Stage Ib cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy role of adjuvant radiotherapy. Obstet Gynecol 1987;69:378-81.
27. Rettenmaier MA, Casanova DM, Micha JP, Moran MF, Ramsanghani NS, Syed NA, et al. Radical hysterectomy and tailored postoperative radiation therapy in the management of bulky stage lb cervical cancer. Cancer 1989;63:2220-3.
28. Monk BJ, Cha DS, Walker JL, Burger RA, Ramsinghani NS, Manetta A, et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage Ib and IIa cervical carcinoma. Gynecol Oncol 1994;54: 4-9.
29. Kjorstad KE, Martimbeau PW, Iversen T. Stage Ib carcinoma of the cervix, the Norwegian Radium Hospital: results and complications. III. Urinary and gastrointestinal complications. Gynecol Oncol 1983;15: 42-7.